SHOULD we now embark on daring skin-to-skin missions? I am pretty sure this is what some people were asking when they heard that a long-acting HIV prevention drug is now available in Zambia. In a recent act of global health generosity, the United States Government made a remarkable contribution to Zambia’s well-being; 14,850 vials of the innovative injectable PrEP, famously known as Cabotegravir Long Acting (CAB-LA). This momentous donation has not only positioned Zambia at the forefront of African nations but has also marked a historic stride in the global fight against HIV. I caught up with Ministry of Health Director of Infectious Diseases Professor Lloyd Mulenga who explains in detail what Cabotegravir is and why not everyone can take...